Litcius/Paper detail

Structural characterization of <scp>β‐propiolactone</scp> inactivated severe acute respiratory syndrome coronavirus 2 (<scp>SARS‐CoV</scp>‐2) particles

Dmitry Bagrov, Г. С. Глухов, Andrey Moiseenko, Maria G. Karlova, Daniil Litvinov, П. А. Зайцев, Liubov I. Kozlovskaya, Аnna A. Shishova, Anastasia A. Kovpak, Yury Ivin, Anastasia N. Piniaeva, A. S. Oksanich, Viktor P. Volok, Dmitry I. Osolodkin, Aydar A. Ishmukhametov, А.М. Егоров, К. В. Шайтан, М. П. Кирпичников, Olga S. Sokolova

2021Microscopy Research and Technique27 citationsDOIOpen Access PDF

Abstract

The severe COVID-19 pandemic drives the research toward the SARS-CoV-2 virion structure and the possible therapies against it. Here, we characterized the β-propiolactone inactivated SARS-CoV-2 virions using transmission electron microscopy (TEM) and atomic force microscopy (AFM). We compared the SARS-CoV-2 samples purified by two consecutive chromatographic procedures (size exclusion chromatography [SEC], followed by ion-exchange chromatography [IEC]) with samples purified by ultracentrifugation. The samples prepared using SEC and IEC retained more spikes on the surface than the ones prepared using ultracentrifugation, as confirmed by TEM and AFM. TEM showed that the spike (S) proteins were in the pre-fusion conformation. Notably, the S proteins could be recognized by specific monoclonal antibodies. Analytical TEM showed that the inactivated virions retained nucleic acid. Altogether, we demonstrated that the inactivated SARS-CoV-2 virions retain the structural features of native viruses and provide a prospective vaccine candidate.

Topics & Concepts

UltracentrifugeChemistrySize-exclusion chromatographyMonoclonal antibodyCoronavirusSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Atomic force microscopyIon chromatographyTransmission electron microscopyChromatographyCoronavirus disease 2019 (COVID-19)VirologyNucleic acidVirusAntibodyBiochemistryBiologyEnzymeMaterials scienceMedicineNanotechnologyImmunologyInfectious disease (medical specialty)PathologyDiseaseSARS-CoV-2 and COVID-19 ResearchSARS-CoV-2 detection and testingCOVID-19 Clinical Research Studies
Structural characterization of <scp>β‐propiolactone</scp> inactivated severe acute respiratory syndrome coronavirus 2 (<scp>SARS‐CoV</scp>‐2) particles | Litcius